103 related articles for article (PubMed ID: 9720467)
1. Further occurrence of extended-spectrum beta-lactamase-producing Salmonella enteritidis.
Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Krcméryová T; Kubonová K
J Chemother; 1998 Aug; 10(4):291-4. PubMed ID: 9720467
[TBL] [Abstract][Full Text] [Related]
2. Transferable resistance to cefotaxime, ceftazidime, and aztreonam and production of extended-spectrum beta-lactamase in a strain of Salmonella enteritidis.
Blahová J; Králiková K; Krcméry V; Kubonová K
Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):703-5. PubMed ID: 9352270
[No Abstract] [Full Text] [Related]
3. Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
Blahová J; Hupková M; Králiková K; Krcméry V; Lísková A; Kubonová K
Zentralbl Bakteriol; 1998 Jul; 288(1):75-86. PubMed ID: 9728407
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
Blahová J; Králiková K; Krcméry V; Schäfer V
J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
[TBL] [Abstract][Full Text] [Related]
5. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
Babálová M; Krălíková K; Krcméry V; Kubonová K
Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362
[TBL] [Abstract][Full Text] [Related]
6. In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy.
Barguellil F; Burucoa C; Amor A; Fauchère JL; Fendri C
Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):703-6. PubMed ID: 8565990
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
[TBL] [Abstract][Full Text] [Related]
8. Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
Blahová J; Králiková K; Krcméry V; Torsová V
Zentralbl Bakteriol; 1997 Nov; 286(4):449-55. PubMed ID: 9440193
[TBL] [Abstract][Full Text] [Related]
9. [Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases].
Babálová M; Blahová J; Králiková K; Krcméry V; Hanzen J; Balogová O; Milosovic P
Epidemiol Mikrobiol Imunol; 1999 Feb; 48(1):21-7. PubMed ID: 11038673
[TBL] [Abstract][Full Text] [Related]
10. The origin, by mutation, of high level resistance to ceftazidime and cefotaxime in a clinical isolate of Enterobacter cloacae.
Blahová J; Lesická-Hupková M; Králiková K; Krcméry V; Mikovicová A
J Chemother; 1996 Aug; 8(4):266-9. PubMed ID: 8873831
[TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens.
Luzzaro F; Pagani L; Porta F; Romero E
J Chemother; 1995 Jun; 7(3):175-8. PubMed ID: 7562009
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity and beta-lactamase stability of a new monobactam, B0-1165.
Neu HC; Chin NX
Antimicrob Agents Chemother; 1987 Apr; 31(4):505-11. PubMed ID: 3300528
[TBL] [Abstract][Full Text] [Related]
13. Case report of pediatric gastroenteritis due to CTX-M-15 extended-spectrum beta-lactamase-producing Salmonella enterica serotype enteritidis.
Lee KH; Song W; Jeong SH; Choi KY; Yoon HS; Park MJ
Korean J Lab Med; 2009 Oct; 29(5):461-4. PubMed ID: 19893356
[TBL] [Abstract][Full Text] [Related]
14. Community-onset pyomyositis caused by a Salmonella enterica serovar enteritidis sequence type 11 strain producing CTX-M-15 extended-spectrum β-lactamase.
Hwang JH; Shin GW; Lee CS
J Clin Microbiol; 2015 Apr; 53(4):1439-41. PubMed ID: 25653405
[TBL] [Abstract][Full Text] [Related]
15. [Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit].
Mhand RA; Soukri A; Amarouch H; Mdaghri NE; Benbachir M
Sante; 1999; 9(6):341-4. PubMed ID: 10705312
[TBL] [Abstract][Full Text] [Related]
16. Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing salmonella isolates in Poland.
Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
J Clin Microbiol; 2002 Mar; 40(3):1095-7. PubMed ID: 11880450
[TBL] [Abstract][Full Text] [Related]
17. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa.
Ben-Mahrez K; Rejiba S; Belhadj C; Belhadj O
Res Microbiol; 1999; 150(6):403-6. PubMed ID: 10466408
[TBL] [Abstract][Full Text] [Related]
19. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R
Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178
[TBL] [Abstract][Full Text] [Related]
20. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
